Literature DB >> 454487

Variable binding of propranolol in human serum.

G Sager, O G Nilsen, S Jacobsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 454487     DOI: 10.1016/0006-2952(79)90374-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  19 in total

1.  Interaction of mixed micelles formed from glycocholic acid and lecithin with the protein binding of various drugs.

Authors:  T W Guentert; S Oie; L Paalzow; B M Frey; R Brandt; L J Aarons; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

Review 2.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

3.  Potential applications of free drug level monitoring in cardiovascular therapy.

Authors:  R L Woosley; L A Siddoway; K Thompson; I Cerskus; D M Roden
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

4.  Influence of age on serum protein binding of propranolol.

Authors:  R Bendayan; J A Pieper; R B Stewart; G J Caranasos
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Unaltered serum propranolol binding by meal-induced variations in fatty acids.

Authors:  C A Naranjo; E M Sellers; V Khouw
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

6.  beta-blocker plasma concentrations and inflammatory disease: clinical implications.

Authors:  R E Schneider; H Bishop
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

7.  Increased plasma propranolol binding in myocardial infarction.

Authors:  P A Routledge; W W Stargel; G S Wagner; D G Shand
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

8.  Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction.

Authors:  G Sager; V Hansteen; I Aakesson; S Jacobsen
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

9.  Changes in blood chemistry in hypertensive patients during propranolol therapy.

Authors:  F Andreasen; P Jakobsen; H J Kornerup; E B Pedersen; O L Pedersen; J Weeke
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

10.  In-vitro relationship between protein-binding and free drug concentrations of a water-soluble selective beta-adrenoreceptor antagonist (atenolol) and its interaction with arsenic.

Authors:  M A Alam; M A Awal; N Subhan; M Mostofa
Journal:  J Health Popul Nutr       Date:  2009-02       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.